Female genital neoplasms

PubMed Free Full Text

Ovarian, fallopian tube, and primary peritoneal cancers

Australasia

• Royal College of Pathologists of Australasia
  • Ovary and fallopian tube - malignant setting

Canada

• BCGuidelines
  • Genital Tract Cancers in Females: Ovarian, Fallopian Tube, and Primary Peritoneal Cancers

• Current Oncology
  • Neoadjuvant and Adjuvant Systemic Therapy for Newly Diagnosed Stage II-IV Epithelial Ovary, Fallopian Tube, or Primary Peritoneal Carcinoma: A Practice Guideline [2022]
  • A Pan-Canadian Consensus Statement on First-Line PARP Inhibitor Maintenance for Advanced, High-Grade Serous and Endometrioid Tubal, Ovarian, and Primary Peritoneal Cancers [2022]

• Ontario Health
  • Neoadjuvant and adjuvant systemic therapy for newly diagnosed stage II, III, or IV epithelial ovary, fallopian tube, or primary peritoneal carcinoma [2021]
  • An Ontario Health (Cancer Care Ontario) Clinical Practice Guideline: Consolidation or Maintenance Systemic Therapy for Newly Diagnosed Stage II, III, or IV Epithelial Ovary, Fallopian Tube, or Primary Peritoneal Carcinoma [2021]

• Society of Obstetricians and Gynaecologists of Canada
  • Opportunistic Salpingectomy and Other Methods of Risk Reduction for Ovarian/Fallopian Tube/Peritoneal Cancer in the General Population [2017]

Denmark

• Acta Obstetricia et Gynecologica Scandinavica
  • Ovarian and tubal cancer in Denmark: an update on incidence and survival [2016]

Europe

• European Menopause and Andropause Society
  • Interventions to reduce the risk of ovarian and fallopian tube cancer: A European Menopause and Andropause Society Postition Statement [2017]

France

• Collège National des Gynécologues et Obstétriciens Français
  • Management of epithelial cancer of the ovary, fallopian tube, primary peritoneum. Long text of the joint French clinical practice guidelines issued by FRANCOGYN, CNGOF, SFOG, GINECO-ARCAGY, endorsed by INCa. (Part 2 systemic, intraperitoneal treatment, elderly patients, fertility preservation, follow-up) [2019]
  • Management of epithelial cancer of the ovary, fallopian tube, and primary peritoneum. Long text of the Joint French Clinical Practice Guidelines issued by FRANCOGYN, CNGOF, SFOG, and GINECO-ARCAGY, and endorsed by INCa. Part 1 Diagnostic exploration and staging, surgery, perioperative care, and pathology [2019]

India

• Indian Journal of Medical and Paediatric Oncology
  • Imaging Recommendations for Diagnosis, Staging, and Management of Ovarian and Fallopian Tube Cancers [2023]

International

• International Collaboration on Cancer Reporting
  • Data Set for the Reporting of Ovarian, Fallopian Tube and Primary Peritoneal Carcinoma: Recommendations From the International Collaboration on Cancer Reporting (ICCR) [2022]
  • Ovary, Fallopian Tube and Primary Peritoneal Carcinomas

• International Federation of Gynecology and Obstetrics
  • Cancer of the ovary, fallopian tube, and peritoneum: 2021 update [2021]
  • Cancer of the ovary, fallopian tube, and peritoneum [2018]
  • FIGO's staging classification for cancer of the ovary, fallopian tube, and peritoneum: abridged republication [2015]

• International Journal of Gynecological Cancer
  • An international worldwide retrospective cohort observational study comparing primary cytoreductive surgery with neoadjuvant chemotherapy and interval cytoreductive surgery in patients with carcinoma of the ovary, fallopian tubes, and peritoneum (SUROVA trial) [2024]

Italy

• Journal of Gynecologic Oncology
  • Evaluation of perioperative management of advanced ovarian (tubal/peritoneal) cancer patients: a survey from MITO-MaNGO Groups [2022]

Japan

• Journal of Gynecologic Oncology
  • The 2020 Japan Society of Gynecologic Oncology guidelines for the treatment of ovarian cancer, fallopian tube cancer, and primary peritoneal cancer [2021]

Republic of Korea

• Journal of Gynecologic Oncology
  • Incidence trends for epithelial peritoneal, ovarian, and fallopian tube cancer during 1999–2016: a retrospective study based on the Korean National Cancer Incidence Database [2020]
  • Surgical manual of the Korean Gynecologic Oncology Group: ovarian, tubal, and peritoneal cancers [2016]

Sweden

• BMC Cancer
  • Incidence and survival of epithelial ovarian, fallopian tube, peritoneal, and undesignated abdominal/pelvic cancers in Sweden 1960–2014: A population-based cohort study [2021]

• Gynecologic Oncology
  • Has time to chemotherapy from primary debulking surgery in advanced ovarian cancer an impact on survival? - A population-based nationwide SweGCG study [2024]

United Kingdom

• British Gynaecological Cancer Society
  • British Gynaecological Cancer Society (BGCS) ovarian, tubal and primary peritoneal cancer guidelines: Recommendations for practice update 2024 [2024]

• British Journal of Cancer
  • Validation of the BOADICEA model for epithelial tubo-ovarian cancer risk prediction in UK Biobank [2024]

• Colorectal Disease
  • Governance models to support patient safety when undergoing maximal effort cytoreductive surgery for advanced ovarian/fallopian tube/primary peritoneal cancer – a joint statement of ACPGBI, ASGBI, AUGIS and BGCS [2022]

• National Institute for Health and Care Excellence
  • Rucaparib for maintenance treatment of advanced ovarian, fallopian tube and peritoneal cancer after response to first-line platinum-based chemotherapy [2025]
  • Rucaparib for maintenance treatment of relapsed platinum-sensitive ovarian, fallopian tube or peritoneal cancer [2024]
  • Olaparib with bevacizumab for maintenance treatment of advanced high-grade epithelial ovarian, fallopian tube or primary peritoneal cancer [2024]
  • Olaparib for maintenance treatment of BRCA mutation-positive advanced ovarian, fallopian tube or peritoneal cancer after response to first-line platinum-based chemotherapy [2024]
  • Olaparib for maintenance treatment of relapsed, platinum-sensitive ovarian, fallopian tube or peritoneal cancer after 2 or more courses of platinum-based chemotherapy [2023]
  • Niraparib for maintenance treatment of relapsed, platinum-sensitive ovarian, fallopian tube and peritoneal cancer [2022]
  • Niraparib for maintenance treatment of advanced ovarian, fallopian tube and peritoneal cancer after response to first-line platinum-based chemotherapy [2021]
  • Bevacizumab for treating relapsed, platinum-resistant epithelial ovarian, fallopian tube or primary peritoneal cancer (terminated appraisal) [2015]

• NHS Wales
  • All Wales Guideline for the Management of Ovarian, Fallopian tube and Primary Peritoneal Cancer [2021]

• Obstetrics, Gynaecology and Reproductive Medicine
  • Epithelial ovarian, fallopian tube and primary peritoneal cancer: an overview [2024]

• Royal College of Pathologists
  • Dataset for histopathological reporting of carcinomas and borderline tumours of the ovaries, fallopian tubes and peritoneum [2019]

United States

• College of American Pathologists
  • Protocol for the Examination of Specimens from Patients with Primary Tumors of the Ovary, Fallopian Tube, or Peritoneum [2024]

• National Cancer Institute
  • Ovarian, Fallopian Tube, and Primary Peritoneal Cancer Screening (PDQ®)
  • Ovarian, Fallopian Tube, and Primary Peritoneal Cancer Prevention (PDQ®)
  • Ovarian Epithelial, Fallopian Tube, and Primary Peritoneal Cancer Treatment (PDQ®)

• National Comprehensive Cancer Network
  • NCCN Guidelines® Insights: Ovarian Cancer/Fallopian Tube Cancer/Primary Peritoneal Cancer, Version 3.2024 [2024]
  • Ovarian Cancer/Fallopian Tube Cancer/Primary Peritoneal Cancer

{Related topics}

• Topic
  • Tubal cancer
  • Ovarian cancer
  • Gynecologic oncology